Immune System News and Research

RSS

Researchers identify novel method to develop personalized vaccines for ovarian cancer

Researchers at the University of Connecticut have found a new way to identify protein mutations in cancer cells. The novel method is being used to develop personalized vaccines to treat patients with ovarian cancer.

16 Oct 2014

Parental understanding regarding daily experiences may affect adolescent health, well-being

Adolescents whose parents better understand their daily experiences have better psychological adjustment, suggests a study in the October issue of Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.

16 Oct 2014

New oral biologic medication successfully treats precancerous intestinal inflammation

An oral biologic medication has successfully treated chronic, precancerous inflammation in the intestine, according to results of an animal study authored by an MD/PhD student in the University at Buffalo School of Medicine and Biomedical Sciences.

16 Oct 2014

Researchers identify two microRNA molecules that control chronic inflammation

University of Utah scientists have identified two microRNA molecules that control chronic inflammation, a discovery that one day may help researchers prevent certain fatal or debilitating conditions before they start.

16 Oct 2014

Statement on Ebola epidemic

The Ebola virus is spreading rapidly and to an unexpected extent. The outbreak does not follow the patterns experienced in the past and the virus shows a new disease dynamic in regions, where it has never been recorded before. For this reason, the German National Academy of Sciences Leopoldina, acatech – the German Academy of Science and Engineering, and the Union of the German Academies of Sciences and Humanities have presented a statement on the Ebola epidemic today.

16 Oct 2014

MGH, MIT partner to accelerate development of diagnostic tools and therapies

A novel partnership between Massachusetts General Hospital and Massachusetts Institute of Technology is addressing three major challenges in clinical medicine – improving the diagnosis of disease, developing new approaches to prevent and treat infectious and autoimmune diseases, and developing more accurate methods of diagnosing and treating major neurodegenerative and psychiatric diseases. While individual collaborations between MGH and MIT investigators are nothing new, this formalized strategic partnership is designed to accelerate the development of diagnostic tools and therapies.

16 Oct 2014

TxCell to provide overview of T cellular therapy at 7th National Bio-Therapy Conference

TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present on T cellular therapy for autoimmune diseases at the 7th National Bio-Therapy Conference, October 24-26, 2014 at Great Tang Hotel, Shanghai, China.

16 Oct 2014

New specialist outpatient vaccinations clinic for at-risk people to be opened at MedUni Vienna

At the Medical University of Vienna, Austria's first specialist vaccinations clinic for at-risk groups will open on 22nd October 2014 with an "Open Doors Day". This clinic specialises in patients who, as a result of illness or disease, require personalised care in relation to vaccinations.

16 Oct 2014

Promising vaccination strategy to counteract RSV

Respiratory Syncytial Virus causes severe respiratory tract infections and worldwide claims the lives of 160,000 children each year. Scientists at VIB and Ghent University have succeeded in developing a promising vaccination strategy to counteract this common virus infection.

16 Oct 2014

Research initiative focuses on microbial characteristics of Staphylococcus aureus

Staphylococcus aureus (Sa) and methicillin-resistant staph aureus (MRSA) continue to be among the most common pathogens that overwhelm the immune system, causing serious skin, soft tissue and life-threatening blood-borne infections.

16 Oct 2014

State highlights: Supreme Court to hear N.C. scope-of-practice case; states weigh costs of new hepatitis C drugs

The Supreme Court on Tuesday will consider who can whiten teeth in North Carolina, a seemingly small decision that could have major implications for scope-of-practice throughout the country. In North Carolina Board of Dental Examiners v. Federal Trade Commission, the justices will weigh whether the state dental board's decisions - in this case, a decision to not allow anyone but a dentist to whiten teeth - are immune from antitrust protections typically granted to state agencies (Haberkorn, 10/13).

15 Oct 2014

Researchers awarded grant to develop non-invasive device to detect Human Cytomegalovirus

Researchers from Cardiff and Swansea Universities have been awarded a grant of more than £323k to develop a new, non-invasive, low-cost, and easy to use point of care device to diagnose Human Cytomegalovirus (HCMV).

15 Oct 2014

Inflammation in tissue creates a niche for cancer cells

In order to invade healthy tissue, tumor cells must leave the actual tumor and enter the bloodstream or lymphatic system. For this purpose, they use certain enzymes, proteases that break down the tissue surrounding the tumor, thus opening the way for tumor cells to reach blood or lymphatic vessels. To keep the proteases in check, the body produces inhibitors such as the protein TIMP-1, which thwart the proteases in their work.

15 Oct 2014

Tannic acid may help ease impact of bacterial lung infections in CF patients

By screening over 2,000 approved drugs and natural products, scientists have shown that tannic acid may help ease the impact of bacterial lung infections in cystic fibrosis patients.

14 Oct 2014

TSRI scientists awarded $6.6 million NIH grant to study Lassa fever virus

Scientists from The Scripps Research Institute have been awarded $6.6 million from the National Institutes of Health to lead an investigation of Lassa fever virus, the most prevalent virus-induced hemorrhagic fever disease in Africa.

14 Oct 2014

LCSB scientists characterize new tumour suppressor gene

Scientists at the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg have published their findings that mutations in a gene known as "ARMC5" promote the growth of benign tumours in the adrenal glands and on the meninges: ARMC5 appears to belong to the group of so-called tumour suppressor genes.

14 Oct 2014

Imperial researchers plan to test DTP3 drug in multiple myeloma patients

Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.

14 Oct 2014

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Johnson & Johnson today announced sales of $18.5 billion for the third quarter of 2014, an increase of 5.1% as compared to the third quarter of 2013. Operational results increased 5.8% and the negative impact of currency was 0.7%. Domestic sales increased 11.6%. International sales decreased 0.3%, reflecting operational growth of 1.0% and a negative currency impact of 1.3%.

14 Oct 2014

Cornell University researchers reveal details of how MERS-CoV enters host cells

Cornell University researchers have uncovered details of how the deadly Middle East respiratory syndrome coronavirus (MERS-CoV) enters host cells, and offer possible new avenues for treatment.

14 Oct 2014

Texas health worker contracts Ebola, fueling questions about training and preparedness

The case, the first in which the disease was transmitted in the U.S., raises questions about whether regular hospitals around the country are ready to safely deal with the virus.

13 Oct 2014

Immune System News and Research

Researchers identify novel method to develop personalized vaccines for ovarian cancer

Parental understanding regarding daily experiences may affect adolescent health, well-being

New oral biologic medication successfully treats precancerous intestinal inflammation

Researchers identify two microRNA molecules that control chronic inflammation

Statement on Ebola epidemic

MGH, MIT partner to accelerate development of diagnostic tools and therapies

TxCell to provide overview of T cellular therapy at 7th National Bio-Therapy Conference

New specialist outpatient vaccinations clinic for at-risk people to be opened at MedUni Vienna

Promising vaccination strategy to counteract RSV

Research initiative focuses on microbial characteristics of Staphylococcus aureus

State highlights: Supreme Court to hear N.C. scope-of-practice case; states weigh costs of new hepatitis C drugs

Researchers awarded grant to develop non-invasive device to detect Human Cytomegalovirus

Inflammation in tissue creates a niche for cancer cells

Tannic acid may help ease impact of bacterial lung infections in CF patients

TSRI scientists awarded $6.6 million NIH grant to study Lassa fever virus

LCSB scientists characterize new tumour suppressor gene

Imperial researchers plan to test DTP3 drug in multiple myeloma patients

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Cornell University researchers reveal details of how MERS-CoV enters host cells

Texas health worker contracts Ebola, fueling questions about training and preparedness

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News